| Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake WA Flavahan, Q Wu, M Hitomi, N Rahim, Y Kim, AE Sloan, RJ Weil, ... Nature neuroscience 16 (10), 1373-1382, 2013 | 492 | 2013 |
| EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme BW Day, BW Stringer, F Al-Ejeh, MJ Ting, J Wilson, KS Ensbey, ... Cancer cell 23 (2), 238-248, 2013 | 254 | 2013 |
| A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis HJ Abuhusain, A Matin, Q Qiao, H Shen, N Kain, BW Day, BW Stringer, ... Journal of Biological Chemistry 288 (52), 37355-37364, 2013 | 154 | 2013 |
| A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma BW Stringer, BW Day, RCJ D’Souza, PR Jamieson, KS Ensbey, ZC Bruce, ... Scientific reports 9 (1), 4902, 2019 | 153 | 2019 |
| Extracellular vesicles released by glioblastoma cells stimulate normal astrocytes to acquire a tumor-supportive phenotype via p53 and MYC signaling pathways S Hallal, DM Mallawaaratchy, H Wei, S Ebrahimkhani, BW Stringer, ... Molecular neurobiology 56, 4566-4581, 2019 | 104 | 2019 |
| Differential response of patient-derived primary glioblastoma cells to environmental stiffness TJ Grundy, E De Leon, KR Griffin, BW Stringer, BW Day, B Fabry, ... Scientific reports 6 (1), 23353, 2016 | 102 | 2016 |
| The glycosylphosphatidylinositol-anchored serine protease PRSS21 (testisin) imparts murine epididymal sperm cell maturation and fertilizing ability S Netzel-Arnett, TH Bugge, RA Hess, K Carnes, BW Stringer, AL Scarman, ... Biology of reproduction 81 (5), 921-932, 2009 | 97 | 2009 |
| Eph receptors as therapeutic targets in glioblastoma BW Day, BW Stringer, AW Boyd British journal of cancer 111 (7), 1255-1261, 2014 | 92 | 2014 |
| Inhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motif GA Darnell, TM Antalis, RW Johnstone, BW Stringer, SM Ogbourne, ... Molecular and cellular biology 23 (18), 6520-6532, 2003 | 90 | 2003 |
| Increased sensitivity to ionizing radiation by targeting the homologous recombination pathway in glioma initiating cells YC Lim, TL Roberts, BW Day, BW Stringer, S Kozlov, S Fazry, ZC Bruce, ... Molecular oncology 8 (8), 1603-1615, 2014 | 86 | 2014 |
| NFIB-mediated repression of the epigenetic factor Ezh2 regulates cortical development M Piper, G Barry, TJ Harvey, R McLeay, AG Smith, L Harris, S Mason, ... Journal of Neuroscience 34 (8), 2921-2930, 2014 | 81 | 2014 |
| Neurosphere and adherent culture conditions are equivalent for malignant glioma stem cell lines M Rahman, K Reyner, L Deleyrolle, S Millette, H Azari, BW Day, ... Anatomy & cell biology 48 (1), 25, 2015 | 74 | 2015 |
| Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma SA Greenall, YC Lim, CB Mitchell, KS Ensbey, BW Stringer, AL Wilding, ... Oncogenesis 6 (5), e336-e336, 2017 | 71 | 2017 |
| Glioma surgical aspirate: a viable source of tumor tissue for experimental research BW Day, BW Stringer, J Wilson, RL Jeffree, PR Jamieson, KS Ensbey, ... Cancers 5 (2), 357-371, 2013 | 60 | 2013 |
| The effect of valproic acid in combination with irradiation and temozolomide on primary human glioblastoma cells AN Hosein, YC Lim, B Day, B Stringer, S Rose, R Head, L Cosgrove, ... Journal of neuro-oncology 122, 263-271, 2015 | 55 | 2015 |
| A unique 19 F MRI agent for the tracking of non phagocytic cells in vivo SS Moonshi, C Zhang, H Peng, S Puttick, S Rose, NM Fisk, K Bhakoo, ... Nanoscale 10 (17), 8226-8239, 2018 | 49 | 2018 |
| Structural optimization and pharmacological evaluation of inhibitors targeting dual-specificity tyrosine phosphorylation-regulated kinases (DYRK) and CDC-like kinases (CLK) in … Q Zhou, AF Phoa, RH Abbassi, M Hoque, TA Reekie, JS Font, RM Ryan, ... Journal of Medicinal Chemistry 60 (5), 2052-2070, 2017 | 47 | 2017 |
| Intratumoural heterogeneity underlies distinct therapy responses and treatment resistance in glioblastoma S Akgül, AM Patch, RCJ D’souza, P Mukhopadhyay, K Nones, S Kempe, ... Cancers 11 (2), 190, 2019 | 46 | 2019 |
| Using the apparent diffusion coefficient to identifying MGMT promoter methylation status early in glioblastoma: importance of analytical method D Rundle‐Thiele, B Day, B Stringer, M Fay, J Martin, RL Jeffree, ... Journal of medical radiation sciences 62 (2), 92-98, 2015 | 41 | 2015 |
| ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1 BW Day, BW Stringer, MD Spanevello, S Charmsaz, PR Jamieson, ... Neuro-oncology 13 (11), 1202-1212, 2011 | 39 | 2011 |
Andrew BoydQueensland Institue of Medical ResearchBestätigte E-Mail-Adresse bei qimr.edu.au
